@article{0fc4e726430645d8aa8ff61e7f8b2ee5,
title = "Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial",
abstract = "Imiquimod is an immune response modifier shown to be effective in basal cell carcinoma (BCC).",
keywords = "Adjuvants, Immunologic, Aged, Aged, 80 and over, Aminoquinolines, Antineoplastic Agents, Carcinoma, Basal Cell, Female, Humans, Male, Middle Aged, Skin Neoplasms, Treatment Outcome, Adjuvants, Immunologic, Aged, Aged, 80 and over, Aminoquinolines, Antineoplastic Agents, Carcinoma, Basal Cell, Female, Humans, Male, Middle Aged, Skin Neoplasms, Treatment Outcome",
author = "Ketty Peris and E Campione and T Micantonio and Gc Marulli and Mc Fargnoli and S. Chimenti",
year = "2005",
language = "English",
volume = "31",
pages = "318--323",
journal = "Dermatologic Surgery",
issn = "1076-0512",
publisher = "Lippincott Williams and Wilkins",
}